Sun Pharmaceutical
-
Sun Pharma to acquire Concert Pharmaceuticals
Advancing the potential treatment of Alopecia Areata Sun Pharmaceutical and Concert Pharmaceuticals have executed a definitive agreement under which Sun…
Read More » -
Sun Pharma announces sustained efficacy for ILUMYA
ILUMYA is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase…
Read More »
